Virtus Fund Advisers, LLC
- SEC CIK
- 0001319111
- Latest filing
- Feb 14, 2025
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by Virtus Fund Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q4 2024 holdings
- Shares (Q4 2024)
- 795
- Value
- $108.5K
- % of portfolio
- 0.3%
- Quarters held
- 6
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 795 | $108.5K | 0.3% | +27+3.5% | Added | Holders |
| Q3 2024 | 768 | $88.5K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2024 | 768 | $105.7K | 0.4% | +19+2.5% | Added | Holders |
| Q1 2024 | 749 | $103.3K | 0.4% | +62+9.0% | Added | Holders |
| Q4 2023 | 687 | $90.5K | 0.6% | +285+70.9% | Added | Holders |
| Q3 2023 | 402 | $45.2K | 0.3% | +402 | New | Holders |